Arkolith/Insider Trading/VRDN/Form 4

Myers Scott Dunseth

Chief Executive Officer, DirectorViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Apr 12, 2023
Net Buying
Open-Market Buys
$101K
Open-Market Sells
$0
Net Open-Market Flow
$101K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 12, 2023Buy(P)4K$25.37$101K260K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-012595) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML